In this MedPage Today video, Taylor Brooks, MD, of the Cleveland Clinic Cancer Institute, discusses real-world survival ...
In patients with relapsed or refractory systemic lupus erythematosus, allogeneic CAR-NK cell therapy may offer a safe ...
Leyla O. Shune, MD, describes the available treatment options for patients with chronic graft-versus-host disease who are ...
Please provide your email address to receive an email when new articles are posted on . It is a truism that, “If you operate, you will have complications.” Wise surgeons plan ahead to avoid ...
Andrew Yee, MD, introduces the discussion by reviewing treatment challenges, patient education, and decision-making in ...
Incyte Japan Announces Approval of Minjuvi® (tafasitamab) in Combination with Rituximab and Lenalidomide for ...
The FDA approved epcoritamab plus R 2 on November 18 for the treatment of patients with relapsed or refractory FL. It also granted traditional approval for the treatment of relapsed or refractory FL ...
Refractory angina is an increasingly prevalent clinical syndrome characterized by ongoing ischaemic symptoms despite optimal medical management in patients for whom traditional revascularization is ...
Refractory dry eye in patients with systemic comorbidities can be challenging to manage because the underlying condition or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback